Pharmaceutical News and Articles

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

Pyxis Oncology, Inc. (Nasdaq PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the U.

Camizestrant Demonstrated Highly Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in 1st-Line Advanced HR-Positive Breast Cancer with an Emergent ESR1 Tumor Mutation in SERENA-6 Phase III Trial

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca s camizestrant in combination with a cyclin-

BlueRock Therapeutics Receives FDA Fast Track Designation for OpCT-001 for the Treatment of Primary Photoreceptor Diseases

Berlin, Germany, and Cambridge, MA, USA February 27, 2025 Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidia

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

Poor Sleep Endangering The Health of Two-Thirds of Americans

About two-thirds of Americans are getting too little or too much sleep, risking their health, a new study suggests. In fact, people not getting the right amount

U.S. Ends Funding for Thousands of Global Health Programs

The U.S. government has ended funding for some 5,800 global health programs, cutting off critical support for projects that provide vaccines, life-saving medica

Severe Flu Season Raises Concerns About Brain Complications in Kids

As this year s severe flu season rages across the country, federal health officials are investigating a rise in rare but life-threatening brain complications in

Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications

For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia and is associated with an increased r

Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease

Nonmalignant gynecological diseases (NMGD) are associated with cardiovascular and or cerebrovascular disease (C CVD), according to a systematic review and meta-

Patients Hospitalized With COVID-19 Face Higher Long-Term Risk for Death, Rehospitalization

Individuals previously hospitalized for COVID-19 have an increased risk for subsequent death or hospitalization for various organ disorders up to 30 months afte